Mark S Freedman (M S Freedman)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 14

Top Topics

Myasthenia Gravis

Randomized Controlled Trial

Spectrum Disorder

Multiple Sclerosis

Top Venues

Journal of neurology, neurosurgery, and psychiatry

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques

Journal of neurology

Journal of medical Internet research

This page only lists publications with an associated author ORCID identifier.

Publications

Tammy Jiang, Mathura Shanmugasundaram, Ivan Božin, Mark S Freedman, James B Lewin, Changyu Shen, Tjalf Ziemssen, Douglas L Arnold
Comparative efficacy of diroximel fumarate, ozanimod and interferon beta-1a for relapsing multiple sclerosis using matching-adjusted indirect comparisons. Journal of comparative effectiveness research (2024)
Tomas Kalincik, Sifat Sharmin, Izanne Roos, Jennifer Massey, Ian Sutton, Barbara Withers, Mark S Freedman, Harold Atkins, Eva Krasulova, Eva Kubala Havrdova, Marek Trneny, Tomas Kozak, Joachim Burman, Richard Macdonell, Øivind Torkildsen, Lars Bø, Anne Kristine Lehmann, Basil Sharrack, John Snowden
Effectiveness of autologous haematopoietic stem cell transplantation versus natalizumab in progressive multiple sclerosis. Journal of neurology, neurosurgery, and psychiatry 95 (8) (2024)
Tomas Kalincik, Sifat Sharmin, Izanne Roos, Jennifer Massey, Ian Sutton, Barbara Withers, Mark S Freedman, Harold Atkins, Eva Krasulova, Eva Kubala Havrdova, Marek Trneny, Tomas Kozak, Joachim Burman, Richard Macdonell, Øivind Torkildsen, Lars Bø, Anne Kristine Lehmann, Basil Sharrack, John Snowden
Effectiveness of autologous haematopoietic stem cell transplantation versus natalizumab in progressive multiple sclerosis. Journal of neurology, neurosurgery, and psychiatry (2024)
Jiwon Oh, Virender Bhan, Anthony L Traboulsee, Sarah A Morrow, Liesly Lee, Michael Levin, Courtney S Casserly, Mark S Freedman, Paul S Giacomini, François Émond, Penelope Smyth, Fraser Clift, Daniel Selchen
Health Canada drug approval process: a barrier to personalized care in multiple sclerosis. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques (2024)
Jiwon Oh, Virender Bhan, Anthony L Traboulsee, Sarah A Morrow, Liesly Lee, Michael Levin, Courtney S Casserly, Mark S Freedman, Paul S Giacomini, François Émond, Penelope Smyth, Fraser Clift, Daniel Selchen
Health Canada Drug Approval Process: A Barrier to Personalized Care in Multiple Sclerosis. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques (2024)
Tomas Kalincik, Sifat Sharmin, Izanne Roos, Jennifer Massey, Ian Sutton, Barbara Withers, Mark S Freedman, Harold Atkins, Eva Krasulova, Eva Kubala Havrdova, Marek Trneny, Tomas Kozak, Joachim Burman, Richard Macdonell, Øivind Torkildsen, Lars Bø, Anne Kristine Lehmann, Basil Sharrack, John Snowden
Effectiveness of autologous haematopoietic stem cell transplantation versus natalizumab in progressive multiple sclerosis. Journal of neurology, neurosurgery, and psychiatry 95 (8) (2024)
Tammy Jiang, Tjalf Ziemssen, Sibyl Wray, Changyu Shen, Karin Söderbärg, James B Lewin, Ivan Božin, Mark S Freedman
Matching-Adjusted Indirect Comparisons of Diroximel Fumarate, Ponesimod, and Teriflunomide for Relapsing Multiple Sclerosis. CNS drugs (2023)
Simon Thebault, Hailey Bergman, Harold L Atkins, Mark S Freedman, John Brooks
CLIPPERS Responsive to Cladribine as a Durable Steroid-Sparing Agent. Neurology(R) neuroimmunology & neuroinflammation 10 (1) (2022)
Mark S Freedman, Carlo Pozzilli, Eva Kubala Havrdova, Alexandre Lemle, Michel Burcklen, Anna Larbalestier, Brian Hennessy, Tatiana Sidorenko, Andrea Vaclavkova, Tomas Olsson, null null
Long-term Treatment With Ponesimod in Relapsing-Remitting Multiple Sclerosis: Results From Randomized Phase 2b Core and Extension Studies. Neurology 99 (8) (2022)
Afolasade Fakolade, Julie Cameron, Odessa McKenna, Marcia L Finlayson, Mark S Freedman, Amy E Latimer-Cheung, Lara A Pilutti
Physical Activity Together for People With Multiple Sclerosis and Their Care Partners: Protocol for a Feasibility Randomized Controlled Trial of a Dyadic Intervention. JMIR research protocols 10 (6) (2021)
Dubravka Dodig, Angela Genge, Daniel Selchen, Mark S Freedman
Complement Inhibition in Myasthenia Gravis and Neuromyelitis Optica Spectrum Disorder. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques (2021)
Tjalf Ziemssen, Daniela Piani-Meier, Bryan Bennett, Chloe Johnson, Katie Tinsley, Andrew Trigg, Thomas Hach, Frank Dahlke, Davorka Tomic, Chloe Tolley, Mark S Freedman
A Physician-Completed Digital Tool for Evaluating Disease Progression (Multiple Sclerosis Progression Discussion Tool): Validation Study. Journal of medical Internet research 22 (2) (2020)
Mark S Freedman, Staley Brod, Barry A Singer, Bruce A Cohen, Brooke Hayward, Fernando Dangond, Patricia K Coyle
Clinical and MRI efficacy of sc IFN β-1a tiw in patients with relapsing MS appearing to transition to secondary progressive MS: post hoc analyses of PRISMS and SPECTRIMS. Journal of neurology 267 (1) (2019)
Heejun Kang, M Hii, M Le, Roger Tam, A Riddehough, Anthony L Traboulsee, Shannon H Kolind, Mark S Freedman, David K B Li
Gadolinium Deposition in Deep Brain Structures: Relationship with Dose and Ionization of Linear Gadolinium-Based Contrast Agents. AJNR. American journal of neuroradiology 39 (9) (2018)